The rationale for combining GLP‐1 receptor agonists with basal insulin-Reference-Cited by-同舟云学术

The rationale for combining GLP‐1 receptor agonists with basal insulin

Published:2013-08 Issue:4 Volume:199 Page:246-249
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Cohen Neale D¹,Audehm Ralph²,Pretorius Elaine³,Kaye Joey⁴,Chapman Leon H¹,Colagiuri Stephen⁵

Affiliation:

1. Baker IDI Heart and Diabetes Institute, Melbourne, VIC.

2. Dianella Community Health, Melbourne, VIC.

3. Diabetes and Endocrine Services, Lyell McEwin Hospital, Adelaide, SA.

4. Sir Charles Gairdner Hospital, Perth, WA.

5. Boden Institute of Obesity, Nutrition, Exercise and Eating Disorders, University of Sydney, Sydney, NSW.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja12.11856

Reference27 articles.

1. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study

2. Effects of Intensive Glucose Lowering in Type 2 Diabetes

3. Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

4. New Drugs for the Treatment of Diabetes

5. Combination therapies of DPP4 inhibitors and GLP1 analogues with insulin in type 2 diabetic patients: a systematic review;Rizos EC;Curr Vasc Pharmacol,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes;Diabetic Medicine;2022-06-26

2. Satisfactory Rapid Response to Xultophy Associated with Meal Tolerance Test (MTT) by Carbohydrate Loading;Asploro Journal of Biomedical and Clinical Case Reports;2021-08-12

3. Satisfactory Control for Glucose Profile by Combined Agents of Xultophy with A Small Dose;Diabetes Research: Open Access;2021-06-08

4. Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist S6 Stimulates Insulin Secretion From Rat Islets;Frontiers in Pharmacology;2021-04-29

5. Effective and convenient treatment of Xultophy with lower doses for elderly diabetic patient;Endocrinology&Metabolism International Journal;2021-04-22